ATE40555T1 - Verfahren zur organischen synthese von oligosacchariden,welche galactosamin- und uronsaeure-motive umfassen, oligosaccharide und ihre biologischen verwendungen. - Google Patents

Verfahren zur organischen synthese von oligosacchariden,welche galactosamin- und uronsaeure-motive umfassen, oligosaccharide und ihre biologischen verwendungen.

Info

Publication number
ATE40555T1
ATE40555T1 AT83402109T AT83402109T ATE40555T1 AT E40555 T1 ATE40555 T1 AT E40555T1 AT 83402109 T AT83402109 T AT 83402109T AT 83402109 T AT83402109 T AT 83402109T AT E40555 T1 ATE40555 T1 AT E40555T1
Authority
AT
Austria
Prior art keywords
oligosaccharids
organic synthesis
uronic acid
methods
acid motifs
Prior art date
Application number
AT83402109T
Other languages
English (en)
Inventor
Jean-Claude Jacquinet
Maurice Petitou
Pierre Sinay
Jean Choay
Original Assignee
Choay Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choay Sa filed Critical Choay Sa
Application granted granted Critical
Publication of ATE40555T1 publication Critical patent/ATE40555T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT83402109T 1982-10-27 1983-10-27 Verfahren zur organischen synthese von oligosacchariden,welche galactosamin- und uronsaeure-motive umfassen, oligosaccharide und ihre biologischen verwendungen. ATE40555T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8218003A FR2535324A1 (fr) 1982-10-27 1982-10-27 Station perfectionnee pour l'epuration d'eaux usees

Publications (1)

Publication Number Publication Date
ATE40555T1 true ATE40555T1 (de) 1989-02-15

Family

ID=9278654

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83402109T ATE40555T1 (de) 1982-10-27 1983-10-27 Verfahren zur organischen synthese von oligosacchariden,welche galactosamin- und uronsaeure-motive umfassen, oligosaccharide und ihre biologischen verwendungen.

Country Status (12)

Country Link
US (1) US4943630A (de)
EP (1) EP0113599B1 (de)
JP (2) JPS59501906A (de)
AT (1) ATE40555T1 (de)
AU (1) AU581167B2 (de)
CA (1) CA1258452A (de)
DE (1) DE3379108D1 (de)
DK (1) DK175970B1 (de)
ES (1) ES527144A0 (de)
FR (1) FR2535324A1 (de)
IE (1) IE56227B1 (de)
WO (1) WO1984001777A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1163772B (it) * 1983-07-13 1987-04-08 Baldacci Lab Spa Oligosaccaridi eterogenei complessabili ed alfa-idosani ad attivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche
US4885361A (en) * 1987-07-31 1989-12-05 Hoffmann-La Roche Inc. Sulfated oligosaccharides
US5380716A (en) * 1988-12-15 1995-01-10 Glycomed, Inc. Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation
US5476924A (en) * 1989-01-27 1995-12-19 Duke University Protecting group for acetals and methods of using the same in the activation of saccharides
AU7742591A (en) * 1990-04-06 1991-10-30 Washington University Anticoagulant oligosaccharides
CA2062715A1 (en) 1990-04-16 1991-10-17 Steve Roth Saccharide compositions, methods and apparatus for their synthesis
US5180674A (en) 1990-04-16 1993-01-19 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US6518051B1 (en) 1991-04-11 2003-02-11 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5705178A (en) * 1991-05-31 1998-01-06 Gliatech, Inc. Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
CA2086224C (en) * 1991-12-31 1998-11-10 John Gormley Compositions comprising anionic glycolipid surfactants
US6750207B1 (en) * 1992-05-01 2004-06-15 Yeda Research And Development Co. Ltd. Compositions for the regulation of cytokine activity
US5861382A (en) * 1992-05-01 1999-01-19 Yeda Research And Development Co. Ltd. Methods for regulation of active TNF-α
DE69316754T2 (de) * 1992-06-01 1998-07-16 Biomembrane Inst Schrittweise entfernung von monosacchariden vom reduzierenden ende von oligosacchariden und verwendungen davon
CA2150552C (en) * 1993-09-30 1999-12-21 Akikazu Takada Antithrombotic
NL9400040A (nl) * 1994-01-10 1995-08-01 Suiker Unie Werkwijze voor het bereiden van polysaccharidederivaten.
EP0837868A1 (de) * 1995-06-29 1998-04-29 Pharmacia & Upjohn Aktiebolag Antikoagulantien.
US5646130A (en) * 1995-06-30 1997-07-08 Ocean University Of Oingdao Low molecular weight sulfated polysaccharides and uses thereof
US5981710A (en) * 1997-07-21 1999-11-09 Baxter International, Inc. Therapeutic hemoglobin composition having isotropically increased size
US6018035A (en) * 1997-07-21 2000-01-25 Baxter International Inc. Reagents for isotropic size enhancement of a peptide, protein, nucleotide or other substrate
AUPO888497A0 (en) * 1997-09-01 1997-09-25 Australian National University, The Use of sulfated oligosaccharides as inhibitors of cardiovascular disease
US6204254B1 (en) 1997-09-12 2001-03-20 Baxter International, Inc. Biocompatible surfaces and a method for their preparation
AUPO976897A0 (en) * 1997-10-14 1997-11-06 Australian National University, The Use of sulfated oligosaccharides in lowering blood triglyceride levels
US6083933A (en) * 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
US7285536B2 (en) * 2001-12-05 2007-10-23 Yeda Research And Development Co., Ltd. Anti-cancer therapeutic compounds
EP1476454A1 (de) * 2002-01-18 2004-11-17 Biotie Therapies Corp. Bindungsepitope für helicobacter pylori und deren verwendung
US20040161476A1 (en) * 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
WO2005092931A1 (en) * 2004-03-26 2005-10-06 Taisho Pharmaceutical Co., Ltd. Preparation process of oligoglycosaminoglycan, and reducing end glucuronic acid type oligochondroitin sulfate and pharmaceutical composition comprising the same
US20050261241A1 (en) * 2004-05-19 2005-11-24 Celsus Biopharmaceuticals, Inc. Use of dermatan sulfates and/or desulfated heparins to treat or prevent heparinoid-induced autoimmune responses
US20090210813A1 (en) 2008-02-15 2009-08-20 Sawczak Stephen D Systems and methods for computer equipment management
WO2009155108A1 (en) 2008-05-30 2009-12-23 Momenta Pharmaceuticals, Inc. Saccharide structures and methods of making and using such structures
CN105131054B (zh) * 2011-11-17 2018-01-19 江苏恒瑞医药股份有限公司 用于制备磺达肝癸钠的中间体及其制备方法、磺达肝癸钠的制备方法
JP7044563B2 (ja) * 2017-01-30 2022-03-30 住友化学株式会社 カルボン酸塩、カルボン酸発生剤、レジスト組成物及びレジストパターンの製造方法
CN110698522B (zh) * 2019-09-19 2021-06-08 中国海洋大学 一种软骨素奇数寡糖单体及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1136620A (en) * 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
AT377493B (de) * 1979-09-19 1985-03-25 Wiedmer Ernst Schraubverschluss mit einem garantiering fuer einen behaelter zur anzeige der erstmaligen oeffnung des behaelters
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity
FR2519987A1 (fr) * 1982-01-15 1983-07-22 Choay Sa Trisaccharides a structures d-glucosamine, acide d-glucuronique, d-glucosamine et leur preparation
FR2504535B1 (fr) * 1981-04-28 1987-08-14 Choay Sa Disaccharides derives d'un acide uronique et d'une glucosamine et compositions pharmaceutiques les contenant pour le controle de la coagulation sanguine
AU563351C (en) * 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
US4435387A (en) * 1982-10-25 1984-03-06 American Cyanamid Company Poly-cation salts of bis (or tris) 4-O-polyhexose-thio-arylene sulfate derivatives

Also Published As

Publication number Publication date
ES8501414A1 (es) 1984-12-16
US4943630A (en) 1990-07-24
WO1984001777A1 (fr) 1984-05-10
DE3379108D1 (en) 1989-03-09
DK313584D0 (da) 1984-06-27
IE832525L (en) 1984-04-27
EP0113599A1 (de) 1984-07-18
JPS59501906A (ja) 1984-11-15
EP0113599B1 (de) 1989-02-01
AU581167B2 (en) 1989-02-16
CA1258452A (fr) 1989-08-15
AU2128583A (en) 1984-05-22
JPH0566392B2 (de) 1993-09-21
FR2535324A1 (fr) 1984-05-04
DK313584A (da) 1984-06-27
IE56227B1 (en) 1991-05-22
DK175970B1 (da) 2005-10-03
ES527144A0 (es) 1984-12-16
JPH05262783A (ja) 1993-10-12
JP2510925B2 (ja) 1996-06-26

Similar Documents

Publication Publication Date Title
ATE40555T1 (de) Verfahren zur organischen synthese von oligosacchariden,welche galactosamin- und uronsaeure-motive umfassen, oligosaccharide und ihre biologischen verwendungen.
BR7907431A (pt) Processo para aplicacao de pontos em ferramentas de perfilar na producao de brinquetes no setor farmaceutico de generos alimenticios ou de catalizadores dispositivo para a realizacao do processo utilizacao de transformadores piezoeletricos para o revestimento das zonas mecanicamente solicitadas da ferramenta a perfilar e processo de alta pressao
BE848943A (fr) Procede de couplage de substances biologiques par des liaisons covalentes,
DE3650278D1 (de) Verfahren zum Herstellen von Graphitfolien.
DE69007697D1 (de) Verfahren zum Herstellen von elastischen, flüssigkeitsgefüllten Lagern mit Druckaufnahme- und Ausgleichskammern.
NL300093I1 (nl) Werkwijze voor de bereiding van organische oligosacchariden die met fragmenten van natuurlijke mucopolysacchariden overeenkomen, de aldus verkregen oligosacchariden en hun biologische toepassing.
DE3364779D1 (en) Substituted 4-aminomethylene chromans or chromenes, process for their preparation and their use in medicines
BE875929A (fr) Procede de production de panneaux cellulosiques
DE3486210D1 (de) Verfahren zum Herstellen von Polsterartikeln.
DE3886800D1 (de) Verfahren zur Herstellung von Kautschuklaminaten.
NL7900770A (nl) Werkwijze voor de bereiding van l-proline door fermentatie.
BR7407025D0 (pt) Processo para o tratamento de residuos ou de aguas residuais para recuperacao de produtos uteis
DE3850921D1 (de) Verfahren zum Herstellen von Floatglas.
DE59008624D1 (de) Verfahren zum Herstellen von kaschierten Formteilen.
SE7706425L (sv) Forfarande for framstellning av polyribonukleotider med aktivitet vid alstrandet av leukocyter och blodplettar
FR2327994A1 (fr) Procede ameliore de preparation de vanadates organiques
DE3888260D1 (de) Verfahren zum Herstellen von Kohlenstoffmaterialien.
BR7900673A (pt) Processo para producao de alcanos substituidos por atomos de cloro e/ou grupos sulfo-cloreto
AT367679B (de) Vorrichtung zum herstellen von faserplatten
ATE33496T1 (de) Verfahren zur herstellung von organischen oligosacchariden uebereinstimmend mit fragmenten von natuerlichen muco-polysacchariden, die erhaltenen oligosaccharide und ihre biologische verwendung.
CH552635A (de) Verfahren zur herstellung von hydrophoben staerkederivaten, nach diesem verfahren hergestellte staerkederivate und deren verwendung.
DE68917284D1 (de) Verfahren zur Herstellung von Laminaten.
DK163180C (da) P-nitrophenyl-3-brom-2,3-diethoxypropionat
BR7803173A (pt) Processo para recuperar produtos organicos volatilizaveis ou suspensoes,e produtos organicos obtidos pelo processo
DE58908102D1 (de) Verfahren zum Herstellen von Halbzeug.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time